Supplying schools with Adrenaline Auto-Injectors

Supplying schools with Adrenaline Auto-Injectors

July 15, 2018

Who can provide a signed order for AAIs for a school?

A written order signed by the principal or head teacher at the school must be provided to enable a supply to be made to the school.

What information should be included in the signed order?

In line with legislation requirements;

The order must be signed by the principal or head teacher at the school concerned and state”

(i) the name of the school for which the medicinal product is required,

(ii) the purpose for which that product is required, and

(iii) the total quantity required

Ideally appropriately headed paper should be used, however this is not a legislative requirement.

A suggested Letter template to Pharmacy to obtain an AAI that schools may find useful is included in the Department of Health Guidance on the use of adrenaline auto-injectors in schools.

Only those institutions described in Regulation 22 of the Human Medicines (Amendment) (No.2) Regulations 2014 may legally hold spare AAIs without named individual prescriptions.

How many AAIs can a school obtain?

The number of AAIs that can be obtained by individual schools is not specified in legislation. Schools will be able to purchase AAIs from a pharmacy in small quantities provided this takes place on an occasional basis and is not for profit, thus in line with MHRA guidance  for pharmacists on the repeal of section 10(7) of the Medicines Act 1968. Pharmacists should exercise their professional judgement when receiving requests for AAIs from schools.

What records do I need to keep in the pharmacy?

The signed order needs to be retained for two years from the date of supply or an entry made into the Prescription-Only-Medicine (POM) register. Even where the signed order is retained it is good practice to make a record in the POM register for audit purposes. In line with normal record keeping requirement an entry in the POM register must include:

  • Date the POM was supplied
  • Name, quantity and where it is not apparent formulation and strength of POM supplied
  • Name and address, trade, business or profession of the person to whom the medicine was supplied
  • The purpose for which it was sold or supplied.


Pharmacists should be aware of the different strengths of AAIs that are available. The strength required will depend on the patient’s age and bodyweight. Refer to British National Formulary (BNF)  and Summary of Product Characteristics (SPC)  for each product.


Pharmacists should be aware of the different brands of AAIs that are available, and that each brand may have different instructions for administration. Pharmacists should refer to the individual SPCand Patient Information Leaflet (PIL) for each product when counselling the person collecting the AAIs.

The Department of Health advises schools to hold an appropriate quantity of a single brand of AAI device to avoid confusion in administration and training but also that the decision as to how many brands they purchase will depend on local circumstances and is left to the discretion of the school.

What other information could I be asked to provide?

  • Pharmacists could be asked to explain the instructions for administration of AAIs and any associated information.
  • General advice e.g. on storage, disposal of used, miss fired or expired stock.
  • Advising schools on the importance of keeping a record of the spare AAIs held and their expiry date and to ensure they are replaced appropriately.

The Department of Health has published Guidance on the use of adrenaline auto-injectors in schools to support schools in England with their management of AAIs.

Where can I locate information on a school, including head teacher/principal details if required?

There is no centralised database containing details of schools and head teachers across Great Britain. Possible sources of information would include:

Where to go for further information:

More Latest News >

Gluten Free consultation process

In October NHSE&I  confirmed extension of the Gluten Free Food Service in Northamptonshire until 31st March 2021.  We would like...


Ramadan – coronavirus resources for pharmacy teams


An audit has identified that in Northamptonshire there are some patients on long term amiodarone who are not under cardiology...

Giles Owen, Northamptonshire CCG Deputy Director and Head of Prescribing & Medicines Management has previously highlighted in Tablet Press that 4...

Maternity Services MK

Dr. Sanhita Chakrabarti  Clinical Lead Bedfordshire Clinical Commissioning Group requests that pharmacy colleagues in Milton Keynes advise expectant mothers to...

Updated Covid-19 SOP

Community Pharmacy in the context of Coronavirus (Covid-19) SOP has been updated (26.10.20). The changes are highlighted in yellow. C0796-covid-19-community-pharmacy-sop-v4

PQS 2020/21 Part 2 Infection Control/ AMS We have had a number of contractor queries highlighting difficulty identifying local antibiotic formularies in relation to the PQS...

PQS 2020/21

PQS announced for first part of 2020/21 July 13, 2020 A new Pharmacy Quality Scheme (PQS) for the first part...

Flu Vaccination Service

For all Flu Vaccination FAQs and specification, PGD, training requirements and more please see